Cardiovascular Revascularization Medicine PDF

Cardiovascular Revascularization Medicine (CRM) stands as an influential international journal, presenting original laboratory and clinical investigations focused on revascularization therapies in cardiovascular medicine. With a commitment to multidisciplinary perspectives, CRM publishes 12 regular print issues annually, supplemented by an additional special issue. Indexed on Index Medicus and MEDLINE®/PubMed®, the journal plays a pivotal role in disseminating cutting-edge research and insights to a global audience.

Key features and characteristics of CRM include:

1. Scope and Focus: CRM encompasses a broad spectrum of topics within cardiovascular medicine, addressing preclinical and clinical work. This includes pharmacological interventions, restenosis management, percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, genetics and translational science, health services and outcomes research, invasive imaging, regulatory and health policy, technology and innovation, and vascular medicine.
2. Global Influence: The journal, positioned in Washington, DC, provides a unique advantage in reporting on regulatory issues relevant to interventional cardiology and structural heart disease. Its readership spans cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry professionals, fellows in training, and innovators worldwide.
3. Official Journal of CRT Meeting: As the official journal of the Cardiovascular Research Technologies (CRT) meeting, CRM plays a pivotal role in reflecting the latest research and innovations discussed at this premier event. The journal aligns its content with the tracks of the CRT meeting, covering Complex Coronary, Valve and Structural, Endovascular, Imaging and Physiology, Atherosclerosis, Cardiogenic Shock, Technology and Innovation, Regulatory and Healthcare Policy, and Innovations.
4. Competition and Distinctiveness: CRM’s nearest competitors include JACC: Cardiovascular Interventions, Circulation: Cardiovascular Interventions, and EuroIntervention. The journal distinguishes itself through its singular focus on cardiovascular revascularization and structural intervention, offering a unique platform for clinicians and researchers in the field.
5. Article Types and Peer Review: CRM welcomes a variety of article types, including original articles, research letters, reviews, editorials, and special features. The single-blind peer-review process ensures the rigor and quality of published content.

In summary, Cardiovascular Revascularization Medicine emerges as a leading journal at the intersection of laboratory and clinical research, contributing significantly to the advancement of cardiovascular revascularization therapies and structural interventions. Its global reach, association with the CRT meeting, and commitment to diverse aspects of cardiovascular medicine position CRM as a vital resource for professionals in the field.

Volume 46: Pages 1-126 (January 2023)
Volume 47: Pages 1-102 (February 2023)
Volume 48: Pages 1-46 (March 2023)
Volume 49: Pages 1-76 (April 2023)
Volume 50: Pages 1-68 (May 2023)
Volume 51: Pages 1-78 (June 2023)
Volume 52: Pages 1-112 (July 2023)
Volume 53: Pages 1-82 (August 2023)
Volume 54: Pages 1-84 (September 2023)
Volume 55: Pages 1-102 (October 2023)
Volume 56: Pages 1-86 (November 2023)
Volume 57: Pages 1-114 (December 2023)
Volume 58: Pages 1-110 (January 2024)
Volume 59: Pages 1-112 (February 2024)
Volume 60: Pages 1-106 (March 2024)
Volume 61: Pages 1-120 (April 2024)
Volume 62: Pages 1-142 (May 2024)
Volume 63: Pages 1-82 (June 2024)
Volume 64: Pages 1-92 (July 2024)
Volume 65: Pages 1-108 (August 2024)
Volume 66: Pages 1-78 (September 2024)
Volume 67: Pages 1-120 (October 2024)